Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kate Young

5PUBLICATIONS

12CO-AUTHORS

Epidemiological modellingCancer geneticsEconometric and statistical methodsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Apr 10, 2026

Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.

Jan Mikelson, Richard Birnie, Grant McCarthy

|Mar 13, 2026

The broad societal value of pembrolizumab for women's cancer in Canada.

Elizabeth Brook, Karl Patterson, Nishini Wijenayake

|Sep 17, 2025

Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.

Nishini Wijenayake, Daniel Ladino, Karl Patterson

|Mar 12, 2024

Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden.

Lewis Ralph, Kate Young, Navneet Upadhyay

|Jan 31, 2024

Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.

Grant McCarthy, Kate Young, Matthew Madin-Warburton

Pageof 1

Frequent Collaborators

2 joint publications

Grant McCarthy

2 joint publications

Jan Mikelson

2 joint publications

Raquel Aguiar-Ibáñez

2 joint publications

Karl Patterson

2 joint publications

Annabelle Davies

1 joint publications

Vimalanand Shrikant Prabhu

1 joint publications

Christina Ljungcrantz

1 joint publications

Anna Giertz

1 joint publications

Mariana Rosim

1 joint publications

Elizabeth Brook

Frequent Collaborators

2 joint publications

Grant McCarthy

2 joint publications

Jan Mikelson

2 joint publications

Raquel Aguiar-Ibáñez

2 joint publications

Karl Patterson

Top Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos